ACHIEVE P1 - HTN
ACHIEVE P1 - HTN
批准号:
10662512
负责人:
Robert Daniel Brook
金额:
$57.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-24 至 2026-06-30
关键词:
AccelerationAccountingAddressAdoptionAdultAdvocateAlgorithmsAmericanAtherosclerosisBlack raceBlood PressureCOVID-19Cardiovascular DiseasesCaringChronic Kidney FailureCitiesCommunitiesCommunity Health AidesCost AnalysisCoupledDataDiseaseDisparityEarly treatmentEducationEffectivenessEmploymentEnvironmentEventEvidence based practiceFailureFamiliarityGoalsGreat Lakes RegionGuidelinesHealthHealth Services AccessibilityHealth educationHeartHeart DiseasesHeart failureHigh PrevalenceHomeHybridsHypertensionImprove AccessIndividualInequityInterventionLengthLifeLife StyleLinkMaintenanceMedicalMethodsMobile Health UnitsModelingMorbidity - disease rateOutcomePatientsPersonsPharmaceutical PreparationsPharmacistsPhasePractical Robust Implementation and Sustainability ModelPreventionProcessQuasi-experimentResearchResourcesRiskRisk FactorsRoleTarget PopulationsTestingTimeUnited StatesUrban CommunityVaccinatedblack patientblood pressure controlblood pressure elevationblood pressure reductionburden of illnesscardiometabolismcardiovascular disorder riskcardiovascular risk factorcare deliverycare systemscollaborative carecoronavirus diseasecost effectivenessevidence basehealth care availabilityhealth disparityhealth equityhealth inequalitieshealth literacyhypertension controlhypertensivesimplementation/effectivenessimprovedinnovationmHealthmortalityneighborhood disadvantagenoveloutreachpreventprimary outcomeprogramsracial disparitysocial health determinantssocial vulnerabilitysuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Hypertension is the leading risk factor for global morbidity and mortality. Even mild elevations in blood pressure
(BP) are harmful whereby individuals with stage 1 hypertension are at double cardiovascular risk. Black adults
suffer from a higher prevalence, worse control rates, and more frequent adverse health effects from high BP.
They are also at heightened risk for an earlier accelerated progression from mild to more severe hypertension.
Little progress has been made in mitigating health inequities related to high BP. Predominantly Black cities
such as Detroit disproportionately suffer from nearly twice the national average mortality rate due to heart
disease. Mounting evidence shows that pervasive negative social determinants of heath (SDoH) are major
drivers of these inequities and represent a critical barrier to achieving BP control in Black hypertensives. Core
issues include poor access to healthcare and a burdensome system for care linkage especially in under-
resourced settings, low health education and literacy, and structural inadequacies in care delivery including a
failure to address the spectrum of life circumstances that elevate BP and hinder the adoption of salutary
lifestyle changes. In PROJECT 1 of the ACHIEVE GREATER research center, we propose an innovative
approach to identify and control hypertension at its earliest stages in undiagnosed Black adults, potentially
yielding an enormous benefit towards lifetime health equity. Using a hybrid type I effectiveness-implementation
and quasi-experimental design, we will leverage our novel mobile health unite (MHU) platform to implement a
program that links low risk Black adults with stage 1 hypertension to collaborative care delivered by non-
physicians, community health workers (CHWs) and pharmacists, consisting of a personalized, adaptable
approach to lifestyle and life circumstance (PAL2) intervention for 12-months. Core features of PAL2 include the
ability to choose from a menu of readily available interventions that address individual negative SDoH,
culturally sensitive health and lifestyle education, and adaptability over time according to its acceptance,
effectiveness (home BP), and evolving patient needs. If BP remains ≥130/80 mm Hg after 6 months, a
pharmacist-directed medical treatment algorithm will be added to achieve timely BP control. Program benefits
including BP-lowering will be assessed during the implementation (12-months) and maintenance phases (year
2) after linkage to medical care. We aim to show the effectiveness of project 1 to lower home BP after 12
months in 500 Black patients with mild stage 1 hypertension living in disadvantaged communities in Detroit and
to reach the target population. We also aim to evaluate the fidelity and outcomes of project 1 and examine its
cost effectiveness. Improving care access by strategic MHU outreach, coupled with enhanced collaborative
care, can effectively remove barriers, mitigate negative SDoH and improve BP control in Black adults with
hypertension. PROJECT 1 of the ACHIEVE GREATER center represents a novel and scalable model to
advance health equity in urban Black communities across the United States that continue to face disparities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACHIEVE P1 - HTN
-
批准号:10494198
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2021
-
负责人:Robert Daniel Brook
-
依托单位:
ACHIEVE P1 - HTN
-
批准号:10437396
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2021
-
负责人:Robert Daniel Brook
-
依托单位:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
-
批准号:10207776
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2014
-
负责人:Robert Daniel Brook
-
依托单位:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
-
批准号:10427306
-
项目类别:
-
资助金额:$52.75万
-
财政年份:2014
-
负责人:Robert Daniel Brook
-
依托单位:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
-
批准号:10011861
-
项目类别:
-
资助金额:$57.23万
-
财政年份:2014
-
负责人:Robert Daniel Brook
-
依托单位:
COUNTERACT Supplement--ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
-
批准号:10218398
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2011
-
负责人:Robert Daniel Brook
-
依托单位:
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
-
批准号:9754146
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2011
-
负责人:Robert Daniel Brook
-
依托单位:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
-
批准号:7603730
-
项目类别:
-
资助金额:$4.41万
-
财政年份:2007
-
负责人:Robert Daniel Brook
-
依托单位:
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY
-
批准号:7376511
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2006
-
负责人:Robert Daniel Brook
-
依托单位:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
-
批准号:7376546
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2006
-
负责人:Robert Daniel Brook
-
依托单位:
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY
-
批准号:7199830
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2005
-
负责人:Robert Daniel Brook
-
依托单位:
ANGIOTENSIN RECEPTOR BLOCKADE IN AGE DEPENDENT ENDOTHELIAL DYSFUNCTION
-
批准号:7199820
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2005
-
负责人:Robert Daniel Brook
-
依托单位:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
-
批准号:7199869
-
项目类别:
-
资助金额:$14.62万
-
财政年份:2005
-
负责人:Robert Daniel Brook
-
依托单位:
DEPRESSION AND ENDOTHELIAL FUNCTION - DEPEND II
-
批准号:7199811
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:Robert Daniel Brook
-
依托单位:
LEPTIN IN MODULATING VASCLRTONE & ENDOTHELIAL FUNCT OBESE & NORMAL WGHT ADULT
-
批准号:7199887
-
项目类别:
-
资助金额:$2.98万
-
财政年份:2005
-
负责人:Robert Daniel Brook
-
依托单位:
Cardiovascular Linkage between Endothelial Function & AIR Pollution
-
批准号:7039842
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2004
-
负责人:Robert Daniel Brook
-
依托单位:
Depression and Endothelial Function - DEPEND II
-
批准号:7039773
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2004
-
负责人:Robert Daniel Brook
-
依托单位:
Angiotensin Receptor Blockade in Age Dependent Endothelial Dysfunction
-
批准号:7039783
-
项目类别:
-
资助金额:$7.52万
-
财政年份:2004
-
负责人:Robert Daniel Brook
-
依托单位:
Vascular Tissue AngiotensinII & Endothelial Dysfunction in Uncomplicated Obesity
-
批准号:7039802
-
项目类别:
-
资助金额:$10.42万
-
财政年份:2004
-
负责人:Robert Daniel Brook
-
依托单位:
海外基金